Home/Filings/4/A/0001683168-20-000840
4/A//SEC Filing

Matsuda Kazuko 4/A

Accession 0001683168-20-000840

CIK 0001226616other

Filed

Mar 15, 8:00 PM ET

Accepted

Mar 16, 7:17 PM ET

Size

5.5 KB

Accession

0001683168-20-000840

Insider Transaction Report

Form 4/AAmended
Period: 2020-03-13
Matsuda Kazuko
Chief Medical Officer
Transactions
  • Purchase

    Common Stock

    2020-03-13$3.62/sh+2,000$7,240111,746 total
Footnotes (3)
  • [F1]The reported shares were purchased in multiple transactions. The purchase price reported in Column 4 is a weighted average price ranging from $3.54 to $3.69. The reporting person undertakes to provide to MediciNova, Inc., any security holder of MediciNova, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
  • [F2]Includes 289 shares acquired under MediciNova's employee stock purchase plan, which are exempt under Rule 16b-3(c).
  • [F3]This report is being amended to correct the amount of securities beneficially owned in Column 5.

Documents

1 file

Issuer

MEDICINOVA INC

CIK 0001226616

Entity typeother

Related Parties

1
  • filerCIK 0001531140

Filing Metadata

Form type
4/A
Filed
Mar 15, 8:00 PM ET
Accepted
Mar 16, 7:17 PM ET
Size
5.5 KB